The Whole Genome And Exome Sequencing Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Whole Genome And Exome Sequencing Market:
https://www.thebusinessresearchcompany.com/report/whole-genome-and-exome-sequencing-global-market-report
According to The Business Research Company’s Whole Genome And Exome Sequencing
Global Market Report 2024, The whole genome and exome sequencing market size is
expected to see exponential growth in the next few years. It will grow to $4.91
billion in 2028 at a compound annual growth rate (CAGR) of 24.8%. The growth in the forecast period can be
attributed to population genomics initiatives, rising demand for precision
medicine, advancements in single-cell sequencing, expansion of non-invasive
prenatal testing (NIPT), application in rare disease research. Major trends in
the forecast period include expanded clinical adoption, rapid advancements in
sequencing technologies, rise of population-scale genomic studies, integration
of artificial intelligence (AI) and machine learning (ML), expanding
applications in oncology.
The rising demand for personalized medicine is expected to propel the growth of
the whole genome and exome sequencing market in the future. Personalized
medicine is an approach to medical treatment that tailors healthcare decisions
and interventions to the individual characteristics of each patient,
considering factors such as genetics, environment, and lifestyle. Whole genome
and exome sequencing is used in personalized medicine by providing a
comprehensive analysis of an individual's genetic makeup, allowing for tailored
healthcare decisions and interventions based on their unique genetic,
environmental, and lifestyle factors. For instance, in October 2022, according
to the Personalized Medicine Coalition (PMC), a US-based organization that
promotes the understanding and adoption of personalized medicine, more than
75,000 genetic testing products and 300 personalized medicines are expected to
be on the market in 2022. Furthermore, the Food and Drug Administration's
Center for Drug Evaluation and Research (CDER) approved 37 new molecular
entities (NMEs) in 2022. Further, out of the 35 therapeutic NMEs, approximately
34%, which amounts to 12 of them, are classified as personalized. Therefore, the
rising demand for personalized medicine is driving the growth of the whole
genome and exome sequencing market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13957&type=smp
The whole genome and exome sequencing market covered in this report is
segmented –
1) By Product Type: Kits, Instruments
2) By Workflow: Whole Genome Sequencing (WGS), Whole Exome Sequencing (WES)
3) By Applications: Diagnostics, Cancer, Monogenic Disorders, Diabetes, Drug
Discovery And Development, Personalized Medicine, Agriculture And Animal
Research, Other Applications
4) By End user: Research Center, Academic And Government Institutions,
Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End
Users
Major companies operating in the whole genome and exome sequencing markets are
increasing their focus on developing advanced technological solutions, such as
ultra-fast NGS (next-generation sequencing) analysis, to gain a competitive
edge in the market. Ultra-fast NGS analysis is a technological innovation that
enables the processing of next-generation sequencing (NGS) data at an
exceptionally high speed, significantly reducing the time required for genomic
data analysis. For instance, in January 2023, QIAGEN Digital Insights (QDI), a
US-based bioinformatics company, launched the ultra-fast NGS analysis platform.
This platform offers features such as processing a whole genome in 25 minutes
for $1 in cloud computing costs, promoting efficiency, affordability, and
scalability; its technological innovation significantly enhances genomic data
analysis speed and accessibility, thus holding considerable importance in the
whole genome and exome sequencing market by enabling rapid decision-making and
wider adoption of personalized medicine.
The whole genome and exome sequencing market report table of contents includes:
1. Executive Summary
2. Whole
Genome And Exome Sequencing Market Characteristics
3. Whole
Genome And Exome Sequencing Market Trends And Strategies
4. Whole
Genome And Exome Sequencing Market - Macro Economic Scenario
5. Global
Whole Genome And Exome Sequencing Market Size and Growth
.
32. Global Whole Genome And Exome Sequencing Market Competitive Benchmarking
33. Global
Whole Genome And Exome Sequencing Market Competitive Dashboard
34. Key
Mergers And Acquisitions In The Whole Genome And Exome Sequencing Market
35. Whole
Genome And Exome Sequencing Market Future Outlook and Potential Analysis
36.
Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment